Clicky

Replicel Life Sciences Inc(REPCF)

Description: RepliCel Life Sciences Inc. (RepliCel), formerly Newcastle Resources Ltd. is a Canada-based company, engaged in the business of developing and patenting hair follicle cell replication technology. The Company’s cellular replication and implantation technology is designed to rejuvenate damaged, miniaturized hair follicles in balding scalp skin. The Company is developing an autologous cell-based procedure for the treatment of androgenetic alopecia (pattern baldness) and general hair loss in men and women. It is focused on ensuring the safety and demonstrating the efficacy of RepliCel’s cell-based hair regeneration procedure in humans. As of September 30, 2012, the Company‘s subsidiary included TrichoScience Innovations Inc. (TrichoScience).


Keywords: Organ Systems Regeneration Hair Loss Androgenetic Alopecia Alopecia Hair Diseases Human Hair Scalp Folli Animal Anatomy Hair Follicle Integumentary System Pattern Hair Loss

Home Page: www.replicel.com

570 Granville Street
Vancouver, BC V6C 3P1
Canada
Phone: 604 248 8730


Officers

Name Title
Mr. Andrew Schutte Pres, CEO & Director
Dr. Kevin John McElwee Ph.D. Co-Founder & Chief Scientific Officer
Mr. Simon S. Ma B.A., CPA, CA Chief Financial Officer
Dr. Rolf Hoffmann M.D. Chief Medical Officer & Member of Clinical Advisory Board
Mr. R. Lee Buckler B.Ed., L.L.B., LLB Corp. Sec. & Director
Ben Austring Chief Legal Officer & Operations Mang.
Mr. Darrell Panich M.Sc, PMP, CPM Clinical Consultant

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 8.3521
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks